# Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)

> **NCT01291329** · PHASE2 · COMPLETED · sponsor: **Navy General Hospital, Beijing** · enrollment: 160 (estimated)

## Conditions studied

- ST-Elevation Myocardial Infarction

## Interventions

- **GENETIC:** intracoronary human umbilical WJ-MSC transfer

## Key facts

- **NCT ID:** NCT01291329
- **Lead sponsor:** Navy General Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2015-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291329, "Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01291329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*